DRUG · Unmapped registry intervention
PS-341 (bortezomib)
Find medicine records ·
Find other trials using this name
Clinical trial
PS-341 Followed by Removal of Prostate for Those With Prostate Cancer
NCT00425503
Drugs and interventions used in this trial
1 registeredThese interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.
No matching interventions in this trial.
Study at a glance
Registry-backedPS-341 Followed by Removal of Prostate for Those With Prostate Cancer
Design: INTERVENTIONAL · Status: COMPLETED · Phase: PHASE2
Read study objectives, eligibility and outcome measures at ClinicalTrials.govAdvertisement
Conditions
Prostate Neoplasmsunresolved
Interventions
Sponsors & collaborators
Baylor College of Medicinelead sponsor
Millennium Pharmaceuticals, Inc.collaborator
Mapped research locations
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT00425503 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.